TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P4
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -17.04% |
| Q3 2025 | -13.69% |
| Q2 2025 | 5.46% |
| Q1 2025 | 15.93% |
| Q4 2024 | -1.54% |
| Q3 2024 | -2.38% |
| Q2 2024 | 9.97% |
| Q1 2024 | 41.38% |
| Q4 2023 | -17.17% |
| Q3 2023 | -9.75% |
| Q2 2023 | -15.91% |
| Q1 2023 | 66.82% |
| Q4 2022 | -5.17% |
| Q3 2022 | 2.12% |
| Q2 2022 | 6.99% |
| Q1 2022 | 1.03% |
| Q4 2021 | 9.88% |
| Q3 2021 | 48.50% |
| Q2 2021 | 4.60% |
| Q1 2021 | -1.33% |
| Q4 2020 | 60.25% |
| Q3 2020 | 47.94% |
| Q2 2020 | -16.74% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |